Next Article in Journal
Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment
Next Article in Special Issue
Antimicrobial Peptides in Infectious Diseases and Beyond—A Narrative Review
Previous Article in Journal
Prevalence of High-Risk HPV Subtypes and Efficacy of the HPV Vaccine in Preventing Cervical Epithelial Lesions: Survey and Insights from a German Study
Previous Article in Special Issue
Immunomodulation, Bioavailability and Safety of Bacteriocins
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Life
Volume 13
Issue 8
10.3390/life13081638
life-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phenotypic Characterization of Oral Mucor Species from Eurasian Vultures: Pathogenic Potential and Antimicrobial Ability

by
Catarina Raposo
1,2,†,
Isa Serrano
1,2,*,†,
Eva Cunha
1,2,
Maria Patrícia Couto
1,2,
Filipa Lopes
3,
María Casero
4,
Luís Tavares
1,2 and
Manuela Oliveira
1,2
1
CIISA—Center for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Avenida da Universidade Técnica, 1300-477 Lisboa, Portugal
2
Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 1300-477 Lisboa, Portugal
3
CERAS—Centro de Estudos e Recuperação de Animais Selvagens, Quinta da Senhora de Mércules, 6000-909 Castelo Branco, Portugal
4
RIAS Centro de Recuperação e Investigação de Animais Selvagens, Rua do Parque Natural da Ria Formosa, Quelfes, 8700-194 Olhão, Portugal
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Life 2023, 13(8), 1638; https://doi.org/10.3390/life13081638
Submission received: 11 July 2023 / Revised: 24 July 2023 / Accepted: 25 July 2023 / Published: 27 July 2023
(This article belongs to the Special Issue Bacteriocin, Antimicrobial Peptide, and Antibiotics: Current Insights and Application)
Browse Figures
Versions Notes

Abstract

:
Due to poisoning and decline in the food resources of Eurasian vultures, there has been a rise in the number of Griffon (Gyps fulvus) and Cinereous vultures (Aegypius monachus) needing veterinary care. In captivity, vultures often develop oral and other infectious diseases which can affect their survival and the probability of reintroduction in the wild. Therefore, it is important to characterize relevant microbial species present in the oral cavity of vultures, such as Mucor spp. In this work, seven Mucor spp. isolates previously obtained from Gyps fulvus and Aegypius monachus oral swabs collected at two rehabilitation centers in Portugal were characterized regarding their pathogenic enzymatic profile and antimicrobial activity. Isolates were identified by macro and microscopic observation, and PCR and ITS sequencing. Their antimicrobial activity was determined using a collection of pathogenic bacteria and two yeast species. Results showed that 86% of the isolates produced α-hemolysis, 71% expressed DNase, 57% produce lecithinase and lipase, 29% expressed gelatinase, and 29% were biofilm producers. Four isolates showed inhibitory activity against relevant human and veterinary clinical isolates, including Escherichia coli, Enterococcus faecium, Neisseria zoodegmatis, and Staphylococcus aureus. In conclusion, accurate management programs should consider the benefits and disadvantages of Mucor spp. presence in the oral mucosa.

1. Introduction

The existing 23 species of vultures worldwide are specialized scavengers which inhabit rugged and mountainous areas in Europe, Asia, Africa, and America, being extremely important for our ecosystem [1]. Vultures regulate the spreading of pathogenic agents and diseases and contribute to nutrient recycling by removing from the environment animal carcasses before putrefaction [2,3]. Vulture species have undergone dramatic declines in Europe, leading to the extinction of populations in the Alps and the Carpathians across central Europe. Despite this dramatic decline in some European vulture populations, Iberian populations are stable or even increasing due to conservation actions, and play a key role in the future viability of European vulture populations [4]. Currently, 61% of vulture species are threatened with extinction worldwide, and the most rapid declines have occurred in Asia and Africa [1,5]. Old World vultures are the most threatened, with over 80% of species in decline and 75% of species listed as Endangered or Critically Endangered [5]. This serious and long-term reduction is mainly due to illegal poisoning of carcasses of large mammals, either intentionally or unintentionally, decreased carrion supply arising from changes in livestock management practices and health regulations [6], contamination of carrion with veterinary drugs [4,7,8], and the environmental presence of toxic elements such as heavy metals and anticoagulant rodenticides [9,10]. That is, vulture decline was driven by humans [2,11], and it could severely impair their relevant role in ecosystems, from which humans deeply benefit [2].
In Portugal, the Gyps fulvus vulture is considered a Near-Threatened species [12], meaning that “it does not qualify for Critically Endangered, Endangered or Vulnerable now, but is close to qualifying for or is likely to qualify for a threatened category in the near future”[13], and worldwide they are classified as Least Concerned [13]. Aegypius monachus vultures are considered Critically Endangered in Portugal [12], and Near Threatened globally [13]. According to BirdLife International [13], of the four European vultures (Egyptian, Bearded, Griffon, and Cinereous), Griffon vulture (Gyps fulvus) populations are now increasing in Europe, whereas Cinereous vultures (Aegypius monachus) show a slow to moderate decline [1,13].
The remnant scavenger populations are isolated and in urgent need of conservation action assisted by international cooperation and expert consultants [11]. The number of vultures that are admitted to the wildlife rehabilitation and recovery centers in some European protected areas is high [14]. In the recovery centers, the recuperation rate is influenced by several factors, including the debilitation of each individual and the development of infectious diseases such as oral fungal infections [15].
Fungal infections pose a major threat, as mycoses are among the most frequent and serious systemic diseases in birds. The majority of fungal infections are caused by ubiquitous microorganisms that birds are continually exposed to [16]. These opportunistic mycoses could therefore have a major impact on populations because they may promote fledgling emaciation and dehydration caused by pain during food swallowing, subsequent difficulty in eating, and eventual death by starvation. In addition, some of these mycoses can be life-threatening if they become invasive [15,17,18].
Stress appears to be a defying factor in the development of fungal infections, being associated with captivity, inadequate management, or treatments with antimicrobials for long periods of time [15,17,19]. In addition, physiological stress, in the breeding season, for example, or in captivity, may contribute to the onset of these infections. Wild birds subjected to stress and suffering from immunosuppressive or debilitating diseases, malnutrition, and unsanitary conditions, can develop oral mycosis, with clinical lesions being more frequent in animals in captivity and in the offspring than in free-range wild birds and adults, respectively [17,18]. However, a recent study reported an outbreak of thrush-like lesions in the oral cavity of wild nestling vultures due to the consumption of livestock carcasses exposed to veterinary antibiotics [17]. Opportunistic fungal infections in the oral mucosa are mainly caused by Candida albicans and Aspergillus fumigatus, but Mucor and Cryptococcus may also have a major role in oral infections [20].
The order Mucorales includes several saprophytic fungi associated with underlying diseases. Mucor is composed by filamentous fungi found in soil, plants, and decaying fruits and vegetables. It belongs to phylum Zygomycota, order Mucorales, and family Mucoraceae [21], and is known for being ubiquitous in nature. Though Mucor is usually not pathogenic, several species are among the various zygomycetes identified as causing mucormycosis, an opportunistic fungal infection transmitted through the inhalation of spores [22]. Some Mucor spp. have been reported as possible etiological agents of meningoencephalitis in birds [23]. Additionally, they are described as being responsible for infections in humans, cattle, and swine [24].
In spite of their potential pathogenic profile, Mucor have important biotechnological potential as they are able to produce several enzymes, such as amylases, lipases, pectinases, and proteases, with many applications in pharmacy and industry [25]. For example, Mucor circinelloides enzymes are used in the biodegradation of diesel oil hydrocarbons [26]. These enzymes are essential proteins from the organisms’ metabolism, but many of them also act as virulence factors, playing an important role in host infection [25].
Moreover, it was already shown that Mucor spp. may have antibacterial activity towards relevant Gram-negative bacteria, namely, Klebsiella pneumoniae, Escherichia coli, Pseudomonas brassicacearu, and Aeromonas hydrophila, and also against Gram-positive bacteria, such as Bacillus cereus and Staphylococcus aureus [27,28]. Furthermore, Mucor spp. may present antifungal activity [27,28].
Considering the biotechnological potential of Mucor spp., the aims of this study were to characterize the pathogenic enzymatic profile and to evaluate the antimicrobial activity of Mucor isolates previously obtained from oral samples of Eurasian vultures in captivity.

2. Materials and Methods

2.1. Mucor Isolates

Mucor isolates under study (n = 7) were previously obtained from oral samples collected from six Gyps fulvus and one Aegypius monachus at two rehabilitation centers (Centro de Estudos e Recuperação de Animais Selvagens, CERAS, Castelo Branco (n = 2), and Centro de Recuperação e Investigação de Animais Selvagens, RIAS, Olhão (n = 5)), where they were recovering from bad nutrition and debility [29] (Table 1).
Being a ubiquitous species, Mucor isolates were likely transmitted through food or the environment. Oral samples were previously collected with AMIES swabs and transported to the Laboratory of Mycology of the Faculty of Veterinary Medicine, University of Lisbon, Portugal (FMV-ULisboa) [29]. The samples were cultured in Sabouraud Dextrose (SD) Agar and incubated for 5 days at 27 °C. After incubation, it was possible to presumptively identify seven isolates as Mucor spp. through macroscopic and microscopic evaluation, which were selected for this study. Isolates were maintained in SD agar at room temperature throughout the assays [30].

2.2. DNA Extraction

DNA extraction was carried out using the kit NucleoSpin Plant II by Macherey-Nagel, following the manufacturer’s instructions. First, the mycelium was washed and mixed in ethanol. Then, after removing the ethanol, the sample was placed in a reaction tube and siliconized glass beads were added along in 200 µL of lysis buffer. After homogenization, chloroform was added, and the sample was centrifuged for 5 min at 11,000 rpm. The supernatant was kept in a centrifuge tube and incubated at 65 °C for 30 min and, after another centrifugation for 2 min, it was collected using the NucleoSpin Filter. Again, the supernatant was placed in a reaction tube and the filter discarded. Afterwards, 450 µL of binding buffer were added and mixed, and the sample was put in a new collecting tube (NucleoSpin Plant II). Then, another centrifugation at 11,000 rpm was carried out for 1 min and the flow-through discarded. After this step, 400 µL of wash buffer were added to the NucleoSpin column, the sample was centrifuged again for 1 min, and the flow-through was discarded. Next, 700 µL of the second wash buffer were placed in the column, and another centrifugation was performed for 2 min to remove the buffer and allow the silica membrane to dry. The column was placed in another centrifuge tube together with 50 µL of the elution buffer, previously heated to 70 °C, and further incubated at 70 °C for 5 min. Lastly, the sample was centrifuged for 1 min to elute the DNA.

2.3. DNA Amplification and Sequencing

PCR was carried in a final volume of 25 µL, consisting of 0.4 µL (0.8 µM) of each primer [ITS1 (5′-TCC GTA GGT GAA CCT GCG G) and ITS2 (5′-GCT GCG TTC TTC ATC GAT GC)] [31], 10 µL of DNA, 10 µL of MasterMix (NZYTaq 2× Green, NZYTech®, Lisboa, Portugal) consisting in 1× reaction buffer (50 mM Tris–HCl, pH 9.0, 50 mM NaCl, 2.5 mM MgCl2, 200 µM each of dATP, dCTP, dGTP, dTTP), and 4.2 µL of PCR water. Amplification was performed according to the protocol described by Lau et al. [32] on a Doppio thermocycler (VWR®, Darmstadt, Germany). The conditions applied were: 95 °C for 10 min, followed by 60 cycles of 94 °C for 15 s, 55 °C for 30 s and 72 °C for 30 s, and a final extension at 72 °C for 5 min. Afterwards, to confirm amplification of fungal DNA, PCR products were separated by 1.5% agarose gel electrophoresis stained with Green Safe (NZYTech®), and results visualized by transillumination (ChemiDoc XRS+, Biorad®, Hercules, CA, USA). Then, PCR products were evaluated in Nanodrop to confirm their purity (ratio between absorbance at 260 nm and at 280 nm of ~1.8) and sent to Stabvida (https://www.stabvida.com/pt, accessed on 3 April 2023) for Sanger sequencing, in order to confirm the identification of isolates.

2.4. Phenotypic Characterization of Isolates Pathogenic Potential

To evaluate the virulence potential of the Mucor isolates under study, several tests were performed to assess the production of enzymes such as lipase, lecithinase, gelatinase, DNase, and hemolysins. Biofilm production ability was also tested. All assays were monitored after 24, 48, and 72 h incubation. The tests were conducted in triplicate on three independent days.
Lipase production was evaluated using the lipase medium, containing 1% peptone, 5% sodium chloride, 0.01% calcium chloride, 1% tween 80 (AppliChem GmbII, Darmstadt, Germany) and 2% agar (Difco, Detroit, MI, USA). After isolates’ inoculation and incubation at 37 °C, a positive result was associated with the appearance of a clear halo zone of precipitation around the colony [33].
Lecithinase production was determined using tryptic soy agar (35 g/L) (VWR, Leuven, Belgium) supplemented with 10% egg yolk (VWR, Leuven, Belgium). Isolates were then inoculated in the medium and incubated at 37 °C, after which a white precipitate around the colonies indicated lecithinase production [34].
Nutrient gelatin stab method was performed for the detection of gelatinase production by the Mucor isolates. Five ml of nutrient gelatin medium (Oxoid, Hampshire, UK), containing peptone (5 g/L), beef extract (3 g/L), and gelatin (120 g/L) were placed in a test tube. Then, after isolates’ inoculation and incubation at 37 °C, tubes were refrigerated at 4 °C for 30 min and observed in order to detect gelatin liquefaction [33].
DNase production was evaluated using the DNase medium supplemented with toluidine blue reagent (0.1 g/L) (VWR, Leuven, Belgium). Isolates were inoculated in the medium and further incubated at 37 °C, with a positive result corresponding to the formation of pink halos around the colonies [35].
To test hemolysin production, Columbia agar plates supplemented with 5% sheep blood (COS) (BioMérieux, Marcy-l’Etoile, France) were used. The isolates were inoculated and incubated at 37 °C, and observed for the development of a green or brown halo around the colonies, indicative of α-hemolysis, or of a clear halo, indicative of β-hemolysis [36].
Biofilm production was determined using Red Congo Agar, composed of Brain Heart Infusion (BHI) broth (37 g/L) (VWR, Leuven, Belgium), agar (20 g/L) (VWR, Leuven, Belgium), saccharose (50 g/L), and congo red indicator (8 g/L) (Sigma Aldrich, St. Louis, MI, USA) [37]. Isolates were then inoculated in the medium and further incubated at 37 °C, with the formation of a black halo around the colonies revealing a strong biofilm-forming ability after 24 h, a dark red halo revealing a moderate biofilm-forming ability after 48 h, and a red halo revealing a weak biofilm-forming ability after 72 h [37].
Finally, the virulence index (V. index) (Equation (1)) values were determined for all isolates [38]:
V. index = no. positive virulence factors/no. virulence factors tested

2.5. Antimicrobial Activity

The capacity of the Mucor spp. isolates under study to inhibit different bacteria and yeast species was evaluated against a collection of eight potentially pathogenic bacteria from the Laboratory of Microbiology and Immunology of FMV-ULisboa, belonging to five species: the Gram-negative Escherichia coli, Neisseria zoodegmatis and Pseudomonas aeruginosa, and the Gram-positive Enterococcus faecium and Staphylococcus aureus, as well as two yeast species (Candida spp. and Rhodotorula spp.), also previously isolated from the oral cavity of vultures [29,39,40] (Table 2).
The inhibitory capacity of excreted metabolites produced by the Mucor isolates against bacteria and yeast species was determined by a spot-on-lawn test [41,42].
First, each Mucor isolate was inoculated in three separate tubes containing SD broth and incubated at 27 °C for 24 h (tube 1), 48 h (tube 2) and 72 h (tube 3). By the end of each incubation period, fungal suspensions were filtered using 0.2 µm filters, in order to obtain a sterile filtrate containing the metabolites produced by the isolates under evaluation.
The bacteria mentioned in Table 2 were inoculated in BHI agar plates and incubated at 37 °C for 24 h, while the yeasts were inoculated in Sabouraud medium and incubated at 27 °C for 48 h. Then, microbial suspensions with a concentration of 1 × 107 CFU/mL were prepared in sodium chloride, and inoculated on the surface of Mueller–Hinton agar plates in order to form a uniform lawn of microbial growth.
Afterwards, 10 µL of the sterile filtrate obtained from each Mucor isolate at 24 h, 48 h, and 72 h were spotted on the surface of each microbial lawn, after which plates were incubated for 24 h at 37 °C. Then, plates were observed for the development of inhibition halos in the spot where the Mucor filtrates were spotted.
Experiments were conducted as three independent assays.

3. Results

3.1. Macroscopic and Microscopic Identification of Mucor spp.

The seven Mucor spp. isolates (M1 to M7) previously obtained from oral samples collected from six Gyps fulvus (samples 1, 2, 3, 5, 6, 7) and one Aegypius monachus (sample 4), were first presumptively identified through their macro and microscopic features.
Macroscopically, Mucor typically forms large white or beige colonies after 48 to 96 hours’ incubation, which can become grey or brownish due to the development of spores (Figure 1(1)).
Microscopically, the vegetative mycelium of Mucor isolates is non-septate or sparsely septate, and present broad (6–15 μm) hyphae without stolons and rhizoids, sporangiophores, sporangia, and spores. Some Mucor species produce chlamydospores (Figure 1(2A)), which are asexual spores, thick-walled and non-deciduous, well adapted to maintain viability through periods of dormancy [30,43]. Mucor spores or sporangiospores are round or elongated (Figure 1(2B)), and form apical, globular sporangia. These are round, grey to black in color, and filled with sporangiospores (Figure 1(2C)), and are supported and elevated by a well-defined column-shaped columella (Figure 1(2D)). Columellae are hyaline or dematiaceous and are hardly visible if the sporangium has not been ruptured [30,43].

3.2. Molecular Identification of Mucor spp.

DNA was extracted from the Mucor spp. isolates under study for posterior amplification of the ITS region to allow their molecular identification. As shown in Figure 2, the seven DNA samples produced amplicons with the expected size, 290 bp [31,32] (Figure 2), concordant to Mucor spp.
Afterwards, PCR products were sent to Stabvida for Sanger sequencing. All isolates were identified as Mucor spp., with isolates M2, M3, M4, M5 and M7 being specifically identified as Mucor circinelloides.

3.3. Phenotypic Chacaterization of Mucor spp. Pathogenic Profile

The phenotypic production of enzymes by the Mucor spp. isolates, including lipase, lecithinase, gelatinase, DNase, and hemolysins, was evaluated, together with their biofilm-forming ability (Table 3).
Isolates’ phenotypic ability to produce lecithinase, gelatinase, and DNase increased with incubation time. At 24 h, none of the isolates were able to produce any of the virulence factors tested. At 48 h, all the isolates remained unable to produce gelatinase, but 28.8% (n = 2) were able to produce DNase, and 42.9% (n = 3) were able to produce lecithinase. At 72 h, two isolates (28.8%) were able to produce gelatinase, four (57.1%) were able to produce lecithinase, and five (71.4%) were able to express DNase.
On another end, isolates’ ability to produce lipase or α-hemolysins remained constant throughout the 72 h incubation period, with three isolates (42.9%) being able to produce lipase and six (85.7%) being able to express α-hemolysins.
Regarding biofilm production, it was possible to observe that only isolates M2 and M4 were able to produce biofilm (n = 2, 28.8%). Isolate M4 showed a strong positive result throughout the 72 h of incubation, whereas isolate M2 showed a weak positive result only after 72 h of incubation.
Regarding the V. index, M2, M3, and M6 showed the highest V. index (0.67); followed by M1, and M5 (0.5), and then M4, and M7 (0.33).

3.4. Antimicrobial Potential of the Mucor spp. Isolates

Mucor spp. filtrates were considered to have inhibitory activity against the bacteria and yeasts tested, when at 24 h, 48 h or 72 h, at least two of three replicates evaluated were able to promote microbial growth inhibition.
Overall, Mucor spp. filtrates had no inhibitory activity against the yeasts Candida spp. S2-1 and Rhodotorula spp. S2-2, nor against P. aeruginosa (413/18, ATCC 27853, and Z25.1), and S. aureus ATCC 29213.
The 24 h filtrates presented no inhibitory activity against any of the tested bacteria. Some of the 48 h filtrates were able to inhibit bacterial growth: M3-filtrate was able to inhibit N. zoodegmatis CCUG 52598T; M7-filtrate was able to inhibit E. coli ATCC 25922; and M2 and M4 -filtrate were able to inhibit E. faecium CCUG 36804. Regarding 72 h filtrates, M2-filtrate was able to inhibit N. zoodegmatis CCUG 52598T and E. coli ATCC 25922, M4-filtrate was able to inhibit N. zoodegmatis CCUG 52598T, and M7-filtrate was able to inhibit S. aureus Z25.2 (Table 4).

4. Discussion

In this study, hemolysin activity was the most frequent virulence factor expressed by the Mucor spp. isolates originated from the oral cavity of vultures, as only one isolate did not show signs of hemolysis. According to Nayak et al. [44], several different fungal genera are able to produce hemolysins. Although it is probable that these proteins may be involved in the regulation of fungal growth, the expression of hemolysins able to lyse host cells and other microorganisms could help provide a survival advantage for the fungal species, allowing them to compete with other microorganisms present in the same environment for available nutrients and resources [44].
The second most frequent virulence factor produced by the isolates under study was DNase, as the majority showed a DNase-positive result by the end of the assays. These results are compatible with the ones presented by Thompson and Eribo [45], in which DNase production was detected in all Mucor isolates tested. Unfortunately, studies regarding DNase production by fungi are sparse and little information is available until now. Nevertheless, it has been associated with the ability of a fungal phytopathogen, Cochliobolus heterostrophus, of escaping the action of extracellular maize DNA, which according to Park et al. [46], plays a critical role in cellular defense, being able to trap these fungi [46].
More than half of the isolates were able to produce lecithinase, which is in agreement with studies which have focused on several fungi, like Candida albicans, Cryptococcus neoformans, and Aspergillus, in which the production of lecithinase can be one of the most predominant enzymatic activities expressed [47]. Lecithinase, also called phospholipase C, is an enzyme that splits the phospholipid lecithin, one of the main components of cell membranes, to produce diglyceride and phosphorylcholine, causing toxicity. Additionally, it can cause hemolysis and membrane disruption, leading to cell lysis, hence playing a role in pathogenicity and contributing to fungal virulence [47,48].
It was expected that lipase production by the Mucor isolates was higher, as most isolates investigated in previous studies showed a high capacity to produce this enzyme [49,50]. In one of those studies, seven of 18 Mucorales species, three of which identified as Mucor spp., produced lipase [49]. Moreover, according to Alves et al. [44], among fifty-six Mucor isolates tested, 66% produced lipase [50]. In other studies, the properties of the lipase produced by Mucor griseocyanus, Mucor miehei, and by the new species Mucor lipolyticus Aac-0102 were also evaluated [51,52,53]. In the study herein, only 43% of the isolates were revealed to be able to produce lipase, a subclass of esterases found in all living organisms and used for their normal functioning, performing an important role in the processing of lipids, transport, and digestion for nutrient acquisition. Lipases have particular properties, such as specificity, tolerance to temperature and pH fluctuation, catalytic activity in organic solvents, and nontoxicity, which make them desirable for biotechnological applications [54]. Contribution of lipases to fungal virulence was suggested for several species of Candida [55,56] and other fungi [57], and was associated with their ability of adhesion to host cells and host tissues, initiation of several inflammatory processes by affecting immune cells, and self-defense mediated by lysing competing microbiota [55,57].
Only 29% of Mucor isolates could produce gelatinase. In a previous study, the production of this enzyme was detected in several yeasts and fungi isolated from different zones of the Antarctica sea, particularly in Trichosporon pullulans and in Geomyces pannorum, which revealed high levels of gelatinase production [58]. In another study, the gelatinase produced by Penicillium chrysogenum, Aspergillus ustus, Aspergillus terreus, and Paecilomyces spp. was described as playing a key role in biodegradation [59]. Gelatinase’s main function is to transform gelatin into smaller polypeptides, peptides, and amino acids that can cross the cell and be used by the fungi. It is also considered a virulence factor [33]. In a study with dermatophytes, it was shown that gelatinase production ability contributed to the capacity of these fungi to break down the substrate present in the patient’s skin [33].
Biofilms are dense, highly hydrated cell clusters that are irreversibly attached to a substratum, to an interface or to each other, and are embedded in a self-produced gelatinous matrix composed of extracellular polymeric substances [60]. Biofilm formation can protect fungal pathogens from the innate immune system of the host, and, as they are highly resistant to antifungals, are extremely difficult to eradicate [61,62]. Filamentation in fungi may be a requisite for robust biofilm development and virulence of fungal biofilms, as they often penetrate the substrates on which they grow [60]. According to Sardi et al. [62], biofilm production has been reported in yeasts and fungi such as Candida albicans, Cryptococcus neoformans, Cryptococcus gattii, Rhodotorula spp., Aspergillus fumigatus, Malassezia pachydermatis, Histoplasma capsulatum, Paracoccidioides brasiliensis, Pneumocystis species, Coccidioides immitis, Fusarium spp., Saccharomyces cerevisiae, Trichosporon asahii, Mucorales and Blastoschizomyces. Moreover, Singh et al. [60] showed that some zygomycetes, such as Rhizopus oryzae, Lichtheimia corymbifera, and Rhizomucor pusillus, produced robust, highly intertwined, filamentous, adherent structure-like biofilms. However, in the present study, the production of biofilm was not a common virulence factor expressed by the Mucor isolates, as only less than one third of them were found to be biofilm-producers.
Overall, and regarding the V. index, five Mucor isolates showed a worrying V. index (M1, M2, M3, M5, M6), being able to produce half or more than half of the virulence factors studied. This result is not surprising, since Mucorales express several known virulence factors that can contribute to their pathogenicity and immune evasion [63].
Previously, Mucor spp. was shown to have antibacterial activity towards bacteria and fungi [27,28]. Surprisingly, none of the Mucor filtrates had inhibitory activity against P. aeruginosa, nor yeast. A study aiming to determine the antimicrobial activity of different fungal genera showed that the fungi isolated from the rhizosphere of cultivated plants in Algeria, namely, Alternaria, Aspergillus, Cladosporium, Curvularia, Fusarium, Mucor, and Penicillium, had potential to inhibit S. aureus, E. coli, and K. pneumoniae, and also a lower inhibitory ability against P. aeruginosa [64]. The filtrates with relevant antibacterial activity were obtained from Mucor circinelloides M2, M3, M4, and M7. M. circinelloides is a common species whose predominant form is filamentous, although it can grow as a yeast under certain conditions [65]. The more susceptible bacterium was N. zoodegmatis, presumably due to the thinner cell walls of Gram-negative bacteria leading to more prone action of the fungus on the bacterial growth [27,28]. However, P. aeruginosa, also a Gram-negative, was not susceptible to the action of Mucor filtrates, probably due to the action of efflux pumps [66], the presence of which has not yet been described in N. zoodegmatis, to the best of the authors’ knowledge.
The filtrate with higher inhibitory activity was the one produced by the M2 isolate, which showed inhibition towards three bacterial species. M2 also presented a high V. index, being able to produce lecithinase, DNase, hemolysis, and biofilm (Table 3), which, in spite of being virulence factors, may also contribute to bacterial inhibition. M4 and M7 filtrates showed inhibitory activity against two bacterial species. The M4 isolate was also found to be a strong lipase and biofilm producer, while the M7 isolate was also able to express DNase and hemolysin. M3 showed inhibitory activity only towards N. zoodegmatis CCUG 52598T, and also a high V. index, being a lipase, lecithinase, DNase, and hemolysin producer.
These are interesting results, as they point to the possibility of Mucor spp. presence in the oral cavity of vultures possibly contributing to microorganism control. Conversely, the ability of Mucor to express virulence factors may suggest that these fungi could have an opportunistic impact on vultures’ oral health [17], and consequently delay vultures’ recovery. Therefore, further studies must be performed to confirm if Mucor’s presence in the oral mucosa of vultures results in antimicrobial activity in vivo.

5. Conclusions

The results obtained indicated that Mucor spp. isolated from Near-Threatened Eurasian Griffon vultures, Gyps fulvus, and from one Critically Endangered Cinereous Vulture, Aegypius monachus, have a high virulence capacity, as all isolates were able to produce at least one of the two virulence factors tested. Hemolysis activity, DNase production, and lecithinase were the most frequent virulence factors produced by the isolates under study. Additionally, four Mucor extracts presented inhibitory capacity towards one to three bacterial species, including relevant species such as E. faecium CCUG 36804, N. zoodegmatis CCUG 52598T, E. coli ATCC 25922, and S. aureus Z25.2.
Given the pathogenic profile of the tested fungi and that these vultures are endangered species, further studies should be developed to fully characterize the pathogenic potential of relevant microbial species present in the oral cavity of these animals. Although this fungus is apparently not a disease-causing agent, it can eventually be responsible for opportunistic infections. Therefore, accurate management programs should consider the benefits and the disadvantages of Mucor spp. presence in the oral mucosa of vultures.

Author Contributions

Conceptualization, C.R., E.C. and M.O.; methodology, C.R., E.C., M.P.C. and M.O.; validation, I.S., E.C., L.T. and M.O.; formal analysis, C.R., I.S., E.C. and M.O.; investigation, C.R. and E.C.; resources, M.P.C., F.L., M.C., L.T. and M.O.; data curation, C.R., I.S. and M.O.; writing—original draft preparation, C.R. and I.S.; writing—review and editing, I.S., E.C., M.P.C., F.L., M.C., L.T. and M.O.; supervision, M.O.; project administration, F.L., M.C., L.T. and M.O.; funding acquisition, L.T. and M.O. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by CIISA—Centre for Interdisciplinary Research in Animal. Health, Faculty of Veterinary Medicine University of Lisbon, Project UIDB/00276/2020 (Funded by FCT-Fundação para a Ciência e a Tecnologia); and by the Associate Laboratory for Animal and Veterinary Sciences (Project LA/P/0059/2020-AL4AnimalS).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable. All animals were cared for according to the rules given by the current EU (Directive 2010/63/EC) and national (DL 113/2013) legislation and by the competent authority (Direção Geral de Alimentação e Veterinária, DGAV, https://www.dgav.pt/, accessed on 3 April 2023) in Portugal. Only noninvasive samples were collected during routine procedures, and no ethics committee approval was needed. Trained veterinarians obtained all the samples, following standard routine procedures. No animal experiment was performed in the scope of this research.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy reasons.

Acknowledgments

The authors would like to acknowledge all collaborators from CERAS and RIAS for their support in this study.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Ogada, D.L.; Keesing, F.; Virani, M.Z. Dropping dead: Causes and consequences of vulture population declines worldwide. Ann. N. Y. Acad. Sci. 2012, 1249, 57–71. [Google Scholar] [CrossRef] [PubMed]
  2. Moleón, M.; Sánchez-Zapata, J.; Margalida, A.; Carrete, M.; Owen-Smith, N.; Donázar, J. Humans and Scavengers: The Evolution of Interactions and Ecosystem Services. BioScience 2014, 64, 394–403. [Google Scholar] [CrossRef] [Green Version]
  3. Oliva-Vidal, P.a.S.-G.E.a.M.A. Scavenging in changing environments: Woody encroachment shapes rural scavenger assemblages in Europe. Oikos 2022, 2022, e09310. [Google Scholar] [CrossRef]
  4. Safford, R.; Andevski, J.; Botha, A.; Bowden, C.; Crockford, N.; Garbett, R.; Margalida, A.; Ramírez, I.; Shobrak, M.; Tavares, J.P.; et al. Vulture conservation: The case for urgent action. Bird Conserv. Int. 2019, 29, 1–9. [Google Scholar] [CrossRef] [Green Version]
  5. McClure, C.J.; Westrip, J.R.; Johnson, J.A.; Schulwitz, S.E.; Virani, M.Z.; Davies, R.; Symes, A.; Wheatley, H.; Thorstrom, R.; Amar, A.; et al. State of the world’s raptors: Distributions, threats, and conservation recommendations. Biol. Conserv. 2018, 227, 390–402. [Google Scholar] [CrossRef]
  6. Margalida, A.; Colomer, M. Modelling the effects of sanitary policies on European vulture conservation. Sci. Rep. 2012, 2, 753. [Google Scholar] [CrossRef] [Green Version]
  7. Guitart, R.; Sachana, M.; Caloni, F.; Croubels, S.; Vandenbroucke, V.; Berny, P. Animal poisoning in Europe. Part 3: Wildlife. Vet. J. 2010, 183, 260–265. [Google Scholar] [CrossRef]
  8. Ferguson-Lees, J. Raptors of the World/James Ferguson-Lees and David A. Christie; Helm, C., Ed.; Houghton Mifflin Harcourt: Boston, MA, USA, 2001. [Google Scholar]
  9. Carneiro, M.; Colaço, B.; Brandão, R.; Azorín, B.; Nicolas, O.; Colaço, J.; Pires, M.J.; Agustí, S.; Casas-Díaz, E.; Lavin, S.; et al. Assessment of the exposure to heavy metals in Griffon vultures (Gyps fulvus) from the Iberian Peninsula. Ecotoxicol. Environ. Saf. 2015, 113, 295–301. [Google Scholar] [CrossRef]
  10. Oliva-Vidal, P.; Martínez, J.M.; Sánchez-Barbudo, I.S.; Camarero, P.R.; Colomer, M.; Margalida, A.; Mateo, R. Second-generation anticoagulant rodenticides in the blood of obligate and facultative European avian scavengers. Environ. Pollut. 2022, 315, 120385. [Google Scholar] [CrossRef]
  11. Oliva-Vidal, P.; Hernández-Matías, A.; García, D.; Colomer, M.À.; Real, J.; Margalida, A. Griffon vultures, livestock and farmers: Unraveling a complex socio-economic ecological conflict from a conservation perspective. Biol. Conserv. 2022, 272, 109664. [Google Scholar] [CrossRef]
  12. Cabral, M.J.; Almeida, J.; Almeida, P.R.; Delliger, T.; Ferrand de Almeida, N.; Me, O.; Palmeirim, J.M.; Queirós, A.I.; Rogado, L.; Santos-Reis, M. Livro Vermelho dos Vertebrados de Portugal; Instituto da Conservação da Natureza: Lisbon, Portugal, 2005; p. 659. [Google Scholar]
  13. Ashpole, J.; Butchart, S.; Ekstrom, J.; Everest, J.; Harding, M.; Khwaja, N.; Wheatley, H. BirdLife International IUCN Red List for birds; IUCN: Gland, Switzerland, 2023. [Google Scholar]
  14. Szilágyi, R. The Role of Wildlife Rehabilitation Centers in Species Reintroduction Programmes; EUROPARC Federation: Regensburg, Germany, 2020; pp. 1–30. [Google Scholar]
  15. Garcia, M.E.; Lanzarot, P.; Rodas, V.L.; Costas, E.; Blanco, J.L. Fungal flora in the trachea of birds from a wildlife rehabilitation centre in Spain. Vet. Med. 2007, 52, 464–470. [Google Scholar] [CrossRef]
  16. Shin, S.H.; Ponikau, J.U.; Sherris, D.A.; Congdon, D.; Frigas, E.; Homburger, H.A.; Swanson, M.C.; Gleich, G.J.; Kita, H. Chronic rhinosinusitis: An enhanced immune response to ubiquitous airborne fungi. J. Allergy Clin. Immunol. 2004, 114, 1369–1375. [Google Scholar] [CrossRef]
  17. Pitarch, A.; Gil, C.; Blanco, G. Oral mycoses in avian scavengers exposed to antibiotics from livestock farming. Sci. Total Environ. 2017, 605–606, 139–146. [Google Scholar] [CrossRef] [PubMed]
  18. Velasco, M.C. Candidiasis and cryptococcosis in birds. Semin. Avian Exot. Pet Med. 2000, 9, 75–81. [Google Scholar] [CrossRef]
  19. Balseiro, A.; Espí, A.; Márquez, I.; Pérez, V.; Ferreras, M.C.; Marín, J.F.; Prieto, J.M. Pathological features in marine birds affected by the prestige’s oil spill in the north of Spain. J. Wildl. Dis. 2005, 41, 371–378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Deepa, A.; Nair, B.J.; Sivakumar, T.; Joseph, A.P. Uncommon opportunistic fungal infections of oral cavity: A review. J. Oral Maxillofac. Pathol. 2014, 18, 235–243. [Google Scholar] [CrossRef] [Green Version]
  21. Muszewska, A.; Pawłowska, J.; Krzyściak, P. Biology, systematics, and clinical manifestations of Zygomycota infections. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 1273–1287. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Prakash, H.; Chakrabarti, A. Global Epidemiology of Mucormycosis. J. Fungi 2019, 5, 26. [Google Scholar] [CrossRef] [Green Version]
  23. Orcutt, C.J.; Bartick, T.E. Mucormycotic Meningoencephalitis and Pneumonia in a Chattering Lory (Lorius garrulus). J. Assoc. Avian Vet. 1994, 8, 85–89. [Google Scholar] [CrossRef]
  24. Gnat, S.; Łagowski, D.; Nowakiewicz, A.; Dyląg, M. A global view on fungal infections in humans and animals: Opportunistic infections and microsporidioses. J. Appl. Microbiol. 2021, 131, 2095–2113. [Google Scholar] [CrossRef] [PubMed]
  25. El-Gendi, H.; Saleh, A.K.; Badierah, R.; Redwan, E.M.; El-Maradny, Y.A.; El-Fakharany, E.M. A Comprehensive Insight into Fungal Enzymes: Structure, Classification, and Their Role in Mankind’s Challenges. J. Fungi 2021, 8, 23. [Google Scholar] [CrossRef] [PubMed]
  26. Marchut-Mikolajczyk, O.; Kwapisz, E.; Wieczorek, D.; Antczak, T. Biodegradation of diesel oil hydrocarbons enhanced with Mucor circinelloides enzyme preparation. Int. Biodeterior. Biodegrad. 2015, 104, 142–148. [Google Scholar] [CrossRef]
  27. Aziz, N.; Pandey, R.; Barman, I.; Prasad, R. Leveraging the Attributes of Mucor hiemalis-Derived Silver Nanoparticles for a Synergistic Broad-Spectrum Antimicrobial Platform. Front. Microbiol. 2016, 7, 1984. [Google Scholar] [CrossRef] [Green Version]
  28. Noureen, S.; Shahzad, D.; Naeem, A.; Rizvi, A.; Mughis, Z. Antibacterial Dynamics Of Mucor Species Against Multi-Drug Resistant Bacterial Species. Int. J. Sci. Technol. Res. 2021, 10, 224–228. [Google Scholar]
  29. Couto, M.P.C. The Homeostasis of the Vulture’s Oral Microbiome and its Interkingdom Synergies. Ph.D. Thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, Lisbon, Portugal, 2022. [Google Scholar]
  30. Lass-Flörl, C. Zygomycosis: Conventional laboratory diagnosis. Clin. Microbiol. Infect. 2009, 15, 60–65. [Google Scholar] [CrossRef] [Green Version]
  31. White, T.; Bruns, T.; Lee, S.; Taylor, J.; Innis, M.; Gelfand, D.; Sninsky, J. Amplification and Direct Sequencing of Fungal Ribosomal RNA Genes for Phylogenetics. PCR Protoc. Guide Methods Appl. 1990, 31, 315–322. [Google Scholar]
  32. Lau, A.; Chen, S.; Sorrell, T.; Carter, D.; Malik, R.; Martin, P.; Halliday, C. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J. Clin. Microbiol. 2007, 45, 380–385. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Elavarashi, E.; Kindo, A.J.; Rangarajan, S. Enzymatic and Non-Enzymatic Virulence Activities of Dermatophytes on Solid Media. J. Clin. Diagn. Res. 2017, 11, DC23–DC25. [Google Scholar] [CrossRef] [PubMed]
  34. Arslan, S.; Küçüksari, R. Phenotypic and Genotypic Virulence Factors and Antimicrobial Resistance of Motile Aeromonas spp. from Fish and Ground Beef: Virulence Potential of Motile Aeromonas in Meat. J. Food Saf. 2015, 35, 551–559. [Google Scholar] [CrossRef]
  35. Sánchez, M.; Colom, F. Extracellular DNase activity of Cryptococcus neoformans and Cryptococcus gattii. Rev. Iberoam. Micol. 2010, 27, 10–13. [Google Scholar] [CrossRef] [Green Version]
  36. Buxton, R. Blood Agar Plates and Hemolysis Protocols. Am. Soc. Microbiol. 2005, 15, 1–9. [Google Scholar]
  37. Abdel Halim, R.M.; Kassem, N.N.; Mahmoud, B.S. Detection of Biofilm Producing Staphylococci among Different Clinical Isolates and Its Relation to Methicillin Susceptibility. Open Access Maced. J. Med. Sci. 2018, 6, 1335–1341. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Singh, S.K.; Ekka, R.; Mishra, M.; Mohapatra, H. Association study of multiple antibiotic resistance and virulence: A strategy to assess the extent of risk posed by bacterial population in aquatic environment. Environ. Monit. Assess 2017, 189, 320. [Google Scholar] [CrossRef] [PubMed]
  39. Gomes, D.; Santos, R.; S Soares, R.; Reis, S.; Carvalho, S.; Rego, P.; C Peleteiro, M.; Tavares, L.; Oliveira, M. Pexiganan in Combination with Nisin to Control Polymicrobial Diabetic Foot Infections. Antibiotics 2020, 9, 128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Sousa, A.F.M. Avaliação In Vitro de Estratégias Antimicrobianas Inovadoras para Controlo de Otites Externas por Pseudomonas Aeruginosa No Cão. Ph.D. Thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, Lisbon, Portugal, 2021. [Google Scholar]
  41. Wong Chin, J.M.; Puchooa, D.; Bahorun, T.; Jeewon, R. Antimicrobial properties of marine fungi from sponges and brown algae of Mauritius. Mycology 2021, 12, 231–244. [Google Scholar] [CrossRef]
  42. Cunha, E.; Freitas, F.B.; Braz, B.S.; Silva, J.M.D.; Tavares, L.; Veiga, A.S.; Oliveira, M. Polyphasic Validation of a Nisin-Biogel to Control Canine Periodontal Disease. Antibiotics 2020, 9, 180. [Google Scholar] [CrossRef] [Green Version]
  43. Kurtzman, C.; Fell, J.; Boekhout, T.; Rober, T.V. Methods for Isolation, Phenotypic Characterization and Maintenance of Yeasts. In The Yeasts, 5th ed.; Kurtzman, C.P., Fell, J.W., Boekhout, T., Eds.; Elsevier: London, UK, 2011; pp. r1–r178. [Google Scholar]
  44. Nayak, A.P.; Green, B.J.; Beezhold, D.H. Fungal hemolysins. Med. Mycol. 2013, 51, 1–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Thompson, D.P.; Eribo, B.E. Extracellular enzyme production by Rhizopus and Mucor species on solid media. Can. J. Microbiol. 1984, 30, 126–128. [Google Scholar] [CrossRef]
  46. Park, H.J.; Wang, W.; Curlango-Rivera, G.; Xiong, Z.; Lin, Z.; Huskey, D.A.; Hawes, M.C.; VanEtten, H.D.; Turgeon, B.G. A DNase from a Fungal Phytopathogen Is a Virulence Factor Likely Deployed as Counter Defense against Host-Secreted Extracellular DNA. mBio 2019, 10, 10–1128. [Google Scholar] [CrossRef] [Green Version]
  47. Ghannoum, M.A. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 2000, 13, 122–143. [Google Scholar] [CrossRef]
  48. Sharaf, E.F.; El-Sayed, W.S.; Abosaif, R.M. Lecithinase-producing bacteria in commercial and home-made foods: Evaluation of toxic properties and identification of potent producers. J. Taibah Univ. Sci. 2014, 8, 207–215. [Google Scholar] [CrossRef] [Green Version]
  49. Ko, H.S.; Taguchi, H.; Takizawa, K.; Fukusima, A.; Kim, H.S. The Enzymatic Approach of Zygomycosis-Causing Mucorales. Kor J. Med. Mycol. 2007, 12, 9–17. [Google Scholar]
  50. Alves, M.H.; Campos-Takaki, G.; Porto, A.; Milanez, A. Screening of Mucor spp. for the production of amylase, lipase, polygalacturonase and protease. Braz. J. Microbiol. 2002, 33, 325–330. [Google Scholar] [CrossRef] [Green Version]
  51. Coca Armas, J.; Dustet Mendoza, J.C.; Martínez-Hernández, J. Mucor griseocyanus Lipase: Production, Characterization and Study of Some Catalytic Properties of the Immobilised Enzyme. Food Technol. Biotechnol. 2008, 46, 195. [Google Scholar]
  52. Perraud, R.; Laboret, F. Optimization of methyl propionate production catalysed by Mucor miehei lipase. Appl. Microbiol. Biotechnol. 1995, 44, 321–326. [Google Scholar] [CrossRef]
  53. Nagaoka, K.; Yamada, Y.; Koaze, Y. Studies on Mucor Lipases: Part I. Production of Lipases with a Newly Isolated Mucor sp. Agric. Biol. Chem. 1969, 33, 299–305. [Google Scholar] [CrossRef]
  54. Ali, S.; Khan, S.A.; Hamayun, M.; Lee, I.J. The Recent Advances in the Utility of Microbial Lipases: A Review. Microorganisms 2023, 11, 510. [Google Scholar] [CrossRef]
  55. Gácser, A.; Stehr, F.; Kröger, C.; Kredics, L.; Schäfer, W.; Nosanchuk, J.D. Lipase 8 affects the pathogenesis of Candida albicans. Infect. Immun. 2007, 75, 4710–4718. [Google Scholar] [CrossRef] [Green Version]
  56. Tóth, A.; Németh, T.; Csonka, K.; Horváth, P.; Vágvölgyi, C.; Vizler, C.; Nosanchuk, J.D.; Gácser, A. Secreted Candida parapsilosis lipase modulates the immune response of primary human macrophages. Virulence 2014, 5, 555–562. [Google Scholar] [CrossRef]
  57. Park, M.; Park, S.; Jung, W.H. Skin Commensal Fungus Malassezia and Its Lipases. J. Microbiol. Biotechnol. 2021, 31, 637–644. [Google Scholar] [CrossRef]
  58. Loperena, L.; Soria, V.; Varela, H.; Lupo, S.; Bergalli, A.; Guigou, M.; Pellegrino, A.; Bernardo, A.; Calviño, A.; Rivas, F.; et al. Extracellular enzymes produced by microorganisms isolated from maritime Antarctica. World J. Microbiol. Biotechnol. 2012, 28, 2249–2256. [Google Scholar] [CrossRef] [PubMed]
  59. Abdel-Maksoud, G.; Abdel-Nasser, M.; Sultan, M.H.; Eid, A.M.; Alotaibi, S.H.; Hassan, S.E.; Fouda, A. Fungal Biodeterioration of a Historical Manuscript Dating Back to the 14th Century: An Insight into Various Fungal Strains and Their Enzymatic Activities. Life 2022, 12, 1821. [Google Scholar] [CrossRef] [PubMed]
  60. Singh, R.; Shivaprakash, M.R.; Chakrabarti, A. Biofilm formation by zygomycetes: Quantification, structure and matrix composition. Microbiology 2011, 157, 2611–2618. [Google Scholar] [CrossRef] [Green Version]
  61. Kernien, J.F.; Snarr, B.D.; Sheppard, D.C.; Nett, J.E. The Interface between Fungal Biofilms and Innate Immunity. Front. Immunol. 2017, 8, 1968. [Google Scholar] [CrossRef] [Green Version]
  62. Sardi, J.D.C.O.; Pitangui, N.D.S.; Rodríguez-Arellanes, G.; Taylor, M.L.; Fusco-Almeida, A.M.; Mendes-Giannini, M.J.S. Highlights in pathogenic fungal biofilms. Rev. Iberoam. Micol. 2014, 31, 22–29. [Google Scholar] [CrossRef] [PubMed]
  63. Hassan, M.I.A.; Voigt, K. Pathogenicity patterns of mucormycosis: Epidemiology, interaction with immune cells and virulence factors. Med. Mycol. 2019, 57, S245–S256. [Google Scholar] [CrossRef] [Green Version]
  64. Abouamama, S.; Anis, B.; Abir, S.; Maroua, H.; Sirine, B. Amylolytic and antibacterial activity of filamentous fungi isolated from the rhizosphere of different plants grown in the Tamanghasset region. Heliyon 2023, 9, e14350. [Google Scholar] [CrossRef]
  65. Vellanki, S.; Navarro-Mendoza, M.I.; Garcia, A.; Murcia, L.; Perez-Arques, C.; Garre, V.; Nicolas, F.E.; Lee, S.C. Mucor circinelloides: Growth, Maintenance, and Genetic Manipulation. Curr. Protoc. Microbiol. 2018, 49, e53. [Google Scholar] [CrossRef]
  66. Lorusso, A.B.; Carrara, J.A.; Barroso, C.D.N.; Tuon, F.F.; Faoro, H. Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa. Int. J. Mol. Sci. 2022, 23, 15779. [Google Scholar] [CrossRef]
Life 13 01638 g001 550
Figure 1. (1)—Macroscopic morphology of a Mucor colony; (2)—Microscopic characteristics of Mucor spp. (A)—Chlamydospore; (B)—Conidia; (C)—Sporangia; (D)—Sporangia, columella, and conidiophore. Amplification, 400×. Original.
Figure 1. (1)—Macroscopic morphology of a Mucor colony; (2)—Microscopic characteristics of Mucor spp. (A)—Chlamydospore; (B)—Conidia; (C)—Sporangia; (D)—Sporangia, columella, and conidiophore. Amplification, 400×. Original.
Life 13 01638 g001
Life 13 01638 g002 550
Figure 2. PCR products after separation by 1.5% agarose gel electrophoresis. M1 to M7, Mucor spp. isolates; NC, negative control; PC, positive control. NZYDNA ladder VI (NZYTech®) can be observed in the first and last wells. Original.
Figure 2. PCR products after separation by 1.5% agarose gel electrophoresis. M1 to M7, Mucor spp. isolates; NC, negative control; PC, positive control. NZYDNA ladder VI (NZYTech®) can be observed in the first and last wells. Original.
Life 13 01638 g002
Table
Table 1. Overview of the samples’ origin, including vultures’ species and rehabilitation center in which animals were recovering.
Table 1. Overview of the samples’ origin, including vultures’ species and rehabilitation center in which animals were recovering.
Sample of OriginVultures’ SpeciesRehabilitation Center
1Gyps fulvusCERAS
2Gyps fulvusRIAS
3Gyps fulvusCERAS
4Aegypius monachusRIAS
5Gyps fulvusRIAS
6Gyps fulvusRIAS
7Gyps fulvusRIAS
CERAS, Centro de Estudos e Recuperação de Animais Selvagens; RIAS, Centro de Recuperação e Investigação de Animais Selvagens.
Table
Table 2. Bacterial and yeast isolates used to test the inhibitory capacity of Mucor spp. and their origin.
Table 2. Bacterial and yeast isolates used to test the inhibitory capacity of Mucor spp. and their origin.
Bacteria/Yeast IsolatesOrigin
Escherichia coli ATCC 25922Culture collection
Enterococcus faecium CCUG 36804Culture collection
Neisseria zoodegmatis CCUG 52598TCulture collection
Pseudomonas aeruginosa ATCC 27853Culture collection
Pseudomonas aeruginosa 413/18Isolated from an otitis from a dog
Pseudomonas aeruginosa Z25.1Isolated from a patient with diabetic foot infection
Staphylococcus aureus ATCC 29213Culture collection
Staphylococcus aureus Z25.2Isolated from a patient with diabetic foot infection
Candida spp. S2-1Isolated from the oral cavity of a vulture
Rhodotorula spp. S2-2Isolated from the oral cavity of a vulture
Table
Table 3. Phenotypic production of lipase, lecithinase, gelatinase, DNase, hemolysins, and biofilm, by the different Mucor spp. isolates under study, after 24, 48 and 72 h incubation (results from three independent experiments).
Table 3. Phenotypic production of lipase, lecithinase, gelatinase, DNase, hemolysins, and biofilm, by the different Mucor spp. isolates under study, after 24, 48 and 72 h incubation (results from three independent experiments).
Mucor spp. IsolateLipaseLecithinaseGelatinaseDNaseHemolysinBiofilm
24 h48 h72 h24 h48 h72 h24 h48 h72 h24 h48 h72 h24 h48 h72 h24 h48 h72 h
M1 −−−−++−−+−−−α-hemolysis 1 −−−
M2−−−−++−−−−−+α-hemolysis 1 −−+
M3 +++−−+−−−−++α-hemolysis 1 −−−
M4+++−−−−−−−−−- +++
M5−−−−++−−−−−+α-hemolysis 1 −−−
M6+++−−−−−+−++α-hemolysis 1 −−−
M7 −−−−−−−−−−−+α-hemolysis 1 −−−
1 The results were the same at 24 h, 48 h and 72 h. −, not detected; +, detected.
Table
Table 4. Antibacterial inhibitory activity of Mucor spp. filtrates obtained after 48 h and 72 h incubations against bacteria (results from three independent experiments).
Table 4. Antibacterial inhibitory activity of Mucor spp. filtrates obtained after 48 h and 72 h incubations against bacteria (results from three independent experiments).
Mucor spp. Filtrate48 h 172 h 1
M2 E. faecium CCUG 36804N. zoodegmatis CCUG 52598T, E. coli ATCC 25922
M3N. zoodegmatis CCUG 52598T -
M4E. faecium CCUG 36804N. zoodegmatis CCUG 52598T
M7E. coli ATCC 25922S. aureus Z25.2
1 Inhibitory activity of bacterial growth demonstrated in at least two of three independent assays.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Raposo, C.; Serrano, I.; Cunha, E.; Couto, M.P.; Lopes, F.; Casero, M.; Tavares, L.; Oliveira, M. Phenotypic Characterization of Oral Mucor Species from Eurasian Vultures: Pathogenic Potential and Antimicrobial Ability. Life 2023, 13, 1638. https://doi.org/10.3390/life13081638

AMA Style

Raposo C, Serrano I, Cunha E, Couto MP, Lopes F, Casero M, Tavares L, Oliveira M. Phenotypic Characterization of Oral Mucor Species from Eurasian Vultures: Pathogenic Potential and Antimicrobial Ability. Life. 2023; 13(8):1638. https://doi.org/10.3390/life13081638

Chicago/Turabian Style

Raposo, Catarina, Isa Serrano, Eva Cunha, Maria Patrícia Couto, Filipa Lopes, María Casero, Luís Tavares, and Manuela Oliveira. 2023. "Phenotypic Characterization of Oral Mucor Species from Eurasian Vultures: Pathogenic Potential and Antimicrobial Ability" Life 13, no. 8: 1638. https://doi.org/10.3390/life13081638

APA Style

Raposo, C., Serrano, I., Cunha, E., Couto, M. P., Lopes, F., Casero, M., Tavares, L., & Oliveira, M. (2023). Phenotypic Characterization of Oral Mucor Species from Eurasian Vultures: Pathogenic Potential and Antimicrobial Ability. Life, 13(8), 1638. https://doi.org/10.3390/life13081638

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop